Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 150
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 151
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
LATEST NEWS UPDATES | Voluntary Licensing Agreements between MPP and Big Pharma – Increasing Monopoly Power -Richa Chintan

Voluntary Licensing Agreements between MPP and Big Pharma – Increasing Monopoly Power -Richa Chintan

Share this article Share this article
published Published on Nov 23, 2021   modified Modified on Nov 24, 2021

-Newsclick.in

The recent agreements between Medicine Patent Pool and Big Pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further.

The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with the anti-viral pill to be sold under the name Paxlovid.

In a recent development, Merck signed an agreement with the Medicines Patent Pool (MPP). Subsequently, Pfizer has also gone ahead and signed a voluntary licensing agreement with MPP. The move is being projected as a responsible gesture from the pharma companies and a success of MPP in expanding affordable access to medicines.

However, experts who have studied the Merck-MPP agreement have raised several concerns. The counterview argues that the agreement between Merck and MPP strengthens the monopoly power of the pharma company.

"The Molnupiravir VL is like a market-guarding wolf dressed as an access-expanding lamb," says Sergiy Kondratuk, International Treatment Preparedness Coalition (ITPC).

Please click here to read more. 


Newsclick.in, 23 November, 2021, https://www.newsclick.in/voluntary-licensing-agreements-MPP-big-pharma-increasing-monopoly-power


Related Articles

 

Write Comments

Your email address will not be published. Required fields are marked *

*

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close